VC Fund Dossiers

These guys are the real deal - they actually understand fintech infrastructure at a technical level and have been grinding in SEA for over a decade before it was cool. The portfolio companies rave about them in a way that's rare - actual quality introductions, not just cheerleading. They're laser-focused on seed fintech, which means they're not distracted by shiny objects or trying to be generalists. The fact that they're getting followed on by top-tier funds like Y Combinator and their 3x returns in Fund I suggest they know how to pick winners early. Only watch-out is they're super niche - if you're not pure fintech or not in their core geographies, you're probably not a fit.

3one4 is one of the more competent mid-tier Indian VCs that actually adds value beyond just writing checks. The Pai duo (no relation) knows their stuff and has built a solid track record with companies like Razorpay becoming genuine successes. They're operationally savvy and won't ghost you post-investment, which is more than you can say for many Indian funds. That said, they're not top-tier brand name VCs, so don't expect them to open every door or lead your Series B. They're workmanlike investors who do their homework and genuinely try to help, but they won't make you cool at founder dinners.

Here's the real deal on A91: They're the 'Sequoia mafia' done right. Founded by three former Sequoia managing partners, they actually know how to build companies, not just write checks. Their $665M third fund closed in April 2025 was one of the largest VC fundraises in India, signaling serious LP confidence. The portfolio speaks volumes - Digit Insurance is expected to go public, and they've had partial exits from Atomberg and spice maker Pushp. What founders love: these guys actually get their hands dirty post-investment and have the operational chops to help scale. What to watch: they're raising average investment sizes to $35-40M with their new fund, so they're moving upmarket and may be less accessible for smaller rounds.

Aavishkaar is impact investing's OG in India - they've been doing 'business with purpose' since 2001 when most VCs were still chasing pure tech plays. While Aavishkaar Capital does focus on sustainable development goals, it stands at 3x Gross Multiple of Investment Capital (MOIC), in terms of returns. "We clock approximately 25 percent in terms of IRR as well. I don't think returns can be compromised just because we are called impact investors," Sushma says. That's solid performance for impact investing. But here's the thing - they're pivoting hard into climate and deeptech now, which means longer hold periods and more patient capital requirements. Track record is below average ... Less insightful than your average VC. Domain know-how limited to 1-2 sectors at best. Stingy culture - some Glassdoor reviews suggest internal culture issues and limited sector expertise beyond their core focus areas. They're great if you're building for underserved markets in financial inclusion or agtech, but expect a very thesis-driven, impact-first approach that may not suit pure growth plays.

Charles Rim is the real deal - a Google M&A veteran who actually knows how to spot exits, evidenced by Moca's quick flip to Grab in under two years. His thesis isn't just marketing fluff; he looks for strong underlying tech value and founder quality, which is why Grab acquired Moca despite its small merchant network - they wanted the tech platform and banking integrations. The fund is small but scrappy with only 15 team members including 1 Partner, 2 Venture Partners and 1 Principal, so you'll get real attention. However, with only 1 new investment annually over the last 5 years, they're incredibly selective - probably too selective for their own growth. Geographic focus limits you to Southeast Asia, but if you're building there, his Google/Yahoo network still opens doors.

Alpha JWC has grown from Indonesia's first independent early-stage venture capital fund into one of the region's most active and trusted investors, reflecting how Southeast Asia's innovation economy has evolved from early experimentation to a more disciplined pursuit of sustainable growth. Their portfolio has seen 6 unicorns, 2 IPOs and 15 acquisitions including key companies like Traveloka, Kopi Kenangan and WeWork. What founders say matters: "Alpha JWC has been a true partner on our transformation journey since day 1. The support that GudangAda has received from Alpha JWC, up until this very day, far exceeds capital injection". They're hands-on to a fault - the teams literally try every dish, every app, every coffee to give candid feedback. The downside? This founder-first obsession means they might overlook business fundamentals if they fall in love with a charismatic CEO.

Alpha Wave is essentially the house that SpaceX built - their single largest investment gave them the credibility to play in the big leagues of AI investing. Recent 50.1% acquisition by Abu Dhabi's IHC signals they're more sovereign wealth fund satellite than pure VC now. The good news: they have serious capital and global reach. The reality check: with 31 partners across 11 offices and 274 investments, you're getting the institutional machine treatment, not boutique attention. Rick Gerson has the Rolodex and board seats, but founders report the firm can feel bureaucratic post-investment. They're betting big on AI infrastructure plays and have the AUM to write large checks, but expect slower decision-making and more process than a traditional growth fund.

Angel Bridge positions itself as true 'hands-on' investors who walk alongside entrepreneurs, but this is classic VC marketing speak—what matters is their actual track record. The real credibility comes from Kasai's operational experience as founding CEO of Heartseed, which actually went public for 37 billion yen, and his Goldman/Bain/Unison pedigree. They've built serious institutional backing with a 26 billion yen Fund III, suggesting they can write meaningful checks. Their bet on Smartpay (leading a $7M round) shows they can spot winners in competitive fintech markets and co-invest with top-tier international VCs like Matrix Partners and Global Founders Capital. The team's consulting backgrounds (McKinsey, BCG) mean they'll probably over-analyze your business model, but they understand how to scale companies systematically.

AngelHub is basically the regulatory good guys who figured out how to play by Hong Kong's strict SFC rules while most others are still stuck in gray zones. They scored a 19x return on The Sandbox exit and have a solid 2.1x equity multiplier across their portfolio. The two female founders are legit - Karen's got serious finance chops from JPM and Karena literally rewrote Hong Kong's crowdfunding regulations. But here's the thing: they're essentially a deal-by-deal SPV platform, not a traditional VC fund, so don't expect hands-on operational support or board seats. They vet hard (less than 5% of deals make it to their platform) but once you're in, you're mostly on your own. Good for founders who want institutional-grade investors without the typical VC drama.

Anicut is one of the more interesting Chennai-based funds trying to be all things to all stages, which can be both a strength and weakness. Their debt heritage gives them real conviction on unit economics - they won't fund your cash-burning dreams without serious revenue discipline. Ashvin's traditional PE background shows in their conservative deal approach, but Dhruv's addition brought some Silicon Valley swagger to the seed side. The 'founder first' messaging is genuine - they actually stick around and don't pressure for quick exits. But founders should know they're very hands-on post-investment and expect regular financial reporting that might feel heavy for early-stage companies.

These two women have built something genuinely different in the Indian VC landscape - they're the anti-hype fund that actually gets shit done. While everyone else was chasing consumer internet unicorns, Ritu and Rema were quietly backing agritech in 2013 when no one cared, and deep science when it wasn't trendy. The physicist-cost accountant combo works: Ritu spots the technical breakthroughs, Rema makes sure the business fundamentals aren't trash. They stay invested longer than most VCs (till Series B/C) and actually roll up their sleeves post-investment. The downside? They're picky as hell and move methodically - if you need quick decisions or don't have real IP/science behind your startup, look elsewhere. But if you're solving hard problems with actual technology for overlooked markets, they're the best partners you'll find in India.

Arbor is a heavyweight in global fintech that founders actually like working with - not always a given in this space. Melissa and Wei have serious Silicon Valley pedigree (Tesla Series A, PayPal Ventures) but they're not trying to impose Valley orthodoxy on every market. A key to Arbor's success has been cultivating a team with a truly global mindset. Guzy emphasizes the importance of embracing local cultures and dynamics rather than trying to impose Silicon Valley norms. Their track record speaks volumes: 6 unicorns including Tabby and Grab, plus they actually get exits (11 acquisitions, 2 IPOs). They're hands-on operators who will work in your business - one partner literally serves as VP/GM at portfolio company InCountry. The downside? They're selective as hell and their fund sizes mean they're hunting bigger deals, so don't expect them to lead your $2M seed.

US venture capital firm Wavemaker Partners has taken over the venture portfolio of Thailand-based Ardent Capital. Wavemaker will manage the portfolio after its merger with Ardent Ventures, the GP's venture capital arm. If you are interested in investment for your own company, or in partnering with any of the Ventures companies, please contact the team at Wavemaker. Thanks for all your support the last five years! Bangkok, July 2016. Here's the reality check: Ardent Capital basically shut down as an active fund in 2016. The founders were solid operators with real exits under their belts, but they couldn't sustain the VC model and handed their portfolio to Wavemaker. "The only time we make a dollar is when we sell a business," Vanzyl says, explaining that Ardent changes no fees whatsoever to its porfolio companies. "If that's how your business model works, we damn well better build stuff that someone wants to buy and someone will pay a lot of money for. Their no-fee model was noble but unsustainable. If you're seeing pitch decks with their name on it today, you're likely dealing with legacy portfolio management, not new investments. They built some solid companies like aCommerce, but as an active fund, they're history.

Arkam's "6-8 companies per year" constraint shows real conviction discipline in a market where most funds spray and pray. The partners have actual operator and exit experience - Chandra backed IPOs at Helion, Srinivasa was at acquired companies worth $100M+. Having Jumbotail hit unicorn status in 2025 gives them street cred, especially since they backed it early. The "Middle India" thesis isn't just marketing fluff - they're genuinely focused on the next 400 million users with family incomes between Rs 3-20 lakhs, which is a massive underserved market. What founders should know: they're hands-on post-investment and stick around through tough times, but they're also thesis-heavy so if you don't fit their Middle India or SaaS-from-India boxes, don't waste your time.

Artha delivers serious numbers - 61% IRR significantly outperforming the 35% industry average for microVCs, with DPI approaching 20%. Anirudh gets his hands dirty - he literally mystery shops portfolio companies like OYO, booking stays himself to ensure quality. He's refreshingly blunt about 'tourist founders' who started companies just because capital was easy, calling the current funding squeeze a necessary correction. The 'winners-only' Select Fund strategy is smart - doubling down on proven portfolio companies rather than constantly sourcing new deals. The portfolio employs 20,000+ people directly and 100,000+ indirectly, showing real scale and impact beyond just paper valuations.

Ascendo is the rare Korean fund that actually gets cross-border expansion - their partners have been there and done that with Formation 8, SoftBank Ventures, and Toss. Aaron's Formation 8 pedigree and Jason's early bet on Toss show they can spot unicorns before they become unicorns. They've got two successful IPOs in their portfolio (ROKIT Healthcare and LIVSMED), which is impressive for a relatively young fund. But here's the catch - their current fund is focused on climate and environmental sectors, so they couldn't even follow-on in their own successful AI portfolio company Medipixel's Series B. That's either incredibly disciplined or incredibly frustrating, depending on your perspective.

Here's the thing about Ascent: they've actually delivered. Two unicorns (Cult.fit, ACKO), eight IPOs, and ten acquisitions in their portfolio isn't marketing fluff. Their 32 percentage points higher exit rate compared to other VCs shows they know how to get money back to LPs. Raja Kumar brings serious regulatory gravitas - former SEBI official who successfully transitioned from civil service to PE, which is rare in India. The downside? They're conservative - typically less than 2 deals per year, only 1 funding round in the last 12 months. But if you're looking for patient capital from someone who understands Indian markets deeply and has $1 billion under management, they're solid. Just don't expect them to move fast or lead every round.

Asia Partners is the real deal - a rare fund that actually knows how to operate at scale, not just write checks. Nash and Rippel have legit operator credentials (Sea IPO, Flipkart exit) that most VCs can only dream of. Their Series C/D focus is smart - they're filling the gap where founders need help transitioning from startup to scale-up, which is exactly where their operating experience shines. The catch? They've only made 9 investments with 1 new one in the last 12 months - they're extremely selective, which means getting their attention requires serious traction. Their portfolio concentration in Singapore-based companies also suggests they prefer proximity for hands-on involvement.

This is the Bertelsmann money machine with Chinese characteristics - Annabelle Long built one of China's most successful VC franchises from scratch and it shows. Since 2008, she's led the team to achieve more than 18 IPOs and more than 40 unicorns, including Linklogis, Lexin, NetEase Cloud Music, SF Intra-City, Stori, Keep, PingCAP, Mobike, and others. The Bertelsmann backing gives them patient capital and global network access that pure financial VCs can't match. They're genuinely good at spotting Chinese companies that can scale globally - see Stori becoming Mexico's newest unicorn. Long is old-school media savvy (started as a TV anchor) which translates to strong founder relationships and board presence. The downside? They're betting heavily on China-to-global expansion at a time when geopolitical headwinds are only getting stronger, and their sweet spot might be getting squeezed by rising US-China tensions.

This is KBank doing corporate VC right – they actually understand the synergy game. They're laser-focused on startups that can integrate with Thailand's largest bank, not just spray-and-pray investing. Thanapong has serious street cred and real exits under his belt, which matters more than most founders realize. The sustainability angle through their Impact Fund isn't just ESG theater – they're putting real money ($17M+ deployed) behind climate tech. Four unicorns in their portfolio including Grab and NIUM proves they can spot winners early. However, being a corporate VC means they move slower than pure-play funds, and you'll definitely be expected to play nice with KBank's strategic interests. Joy deLeon adds solid finance chops and international perspective, but the team is still relatively small for a $255M fund.

BII is the textbook 'relationship investor' - they genuinely mean it when they say they're in it for the long haul. Portfolio companies rave about them being 'first institutional check' partners who help expand globally, even placing former BII principals as CFOs. Founders say BII 'stood by us through every funding round and major business pivot' - that's not marketing speak, that's real commitment. With 3 unicorns (Shiprocket, Licious, Eruditus) in their portfolio, they've proven they can spot and nurture winners. The $500M committed through 2026 shows serious firepower. The downside? Their 'highly selective' approach means they pass on a lot - if you don't fit their thesis perfectly, you're probably out.

BNI Ventures is what you get when a massive state-owned bank decides to play VC - which can be both blessing and curse. On the plus side, they have deep pockets (initial $34.6M commitment) and serious distribution through BNI's banking network, which is actually valuable for fintech and B2B startups needing institutional partnerships. CEO Eddi comes from MCI where he built a solid track record with 20 investments and notable exits like Moka, so he knows the game. The downside? They're still figuring things out (founded 2022, only 4 investments so far) and moving at corporate bank speed rather than startup speed. Their 'strategic synergy' mandate means they're looking for companies that can plug into BNI's ecosystem, which narrows the field considerably.

Here's what they won't tell you: BRI Ventures and CEO Nicko Widjaja are currently embroiled in a major corruption scandal involving $25M in fraudulent investments in TaniHub, with Widjaja detained by Indonesian authorities in September 2025. Their investment activity has basically flatlined - their last disclosed deal was 18 months ago before the July 2025 scandal broke. While they've backed some legitimate winners like Xendit and Bukalapak, the corruption probe involving state-owned enterprise venture arms has chilled the entire Indonesian startup ecosystem, with even other SOE VCs scaling back investments. The fund's corporate backing from Bank BRI gives them deep pockets and local connections, but right now they're in damage control mode dealing with legal fallout.

BII is the UK government's development arm masquerading as a venture fund, with all the bureaucracy that entails. Parliament has criticized them for being 'poorly targeted' on poverty reduction and focusing too much on middle-income countries rather than the most marginalised groups. There's a growing mismatch between BII's ambitious climate and mobilization goals and their entirely shareholder equity-funded balance sheet. Critics question whether their India investments are actually 'additional' to what private investors would do anyway. The new CEO Leslie Maasdorp talks a big game about mobilizing private capital, but BII moves at government speed with development impact frameworks that would make a McKinsey consultant weep. If you want patient capital and can stomach the ESG reporting requirements, they're solid. But don't expect VC-style decision making or risk appetite.

This is Bangkok Bank's CVC arm playing it safe and strategic — they're not chasing unicorns, they're building an ecosystem that feeds business back to the mothership. It is a wholly owned subsidiary of Bangkok Bank and their investments are clearly designed to create synergies with the bank's customer base. The good: they have deep pockets, patient capital, and genuine value-add through Bangkok Bank's massive SME network. The reality check: this isn't a pure VC play — expect slower decisions, more bureaucracy, and investments that need to make sense for the bank's broader strategy. Their portfolio has seen 1 unicorn, namely LINE MAN Wongnai, but most investments are B2B tools that help digitize traditional Thai businesses.

Here's the real talk: I can't find any credible information about Capital Today as a Singapore-based VC fund. Their website doesn't provide useful content, and they don't appear in any major VC databases or industry lists for Singapore. This could mean they're either extremely stealth, very new, or potentially not an active fund. Before taking any meeting, founders should verify this fund actually exists and has real capital to deploy - ask for recent portfolio examples, fund size, and partner backgrounds.

This is Narayana Murthy's family office, which means you're getting the Infosys playbook applied to venture investing - obsessive focus on corporate governance, process over charisma, and long-term value creation. Corporate governance has been at the forefront since day one, with reputation protection being a key priority for this family office. Padaki is notably disciplined on valuations and won't chase inflated deals, warning that struggling startups are selling at 30-40% discounts. They explicitly push founders to build original solutions rather than copy Western models, focusing on global competitiveness and job creation in India. The manufacturing thesis expansion feels strategic given India's moment, but this isn't a fund that'll coddle you through governance issues or overlook fundamentals for growth-at-any-cost narratives.

CE Ventures is essentially a China-market access fund masquerading as a traditional VC. They help companies enter and accelerate in the Chinese market, find strategic investors in China, and manage relations there - Corephotonics insisted Kan sit on their board despite CreditEase only holding 1% because of his China market contribution. They perform 22 percentage points less than average on lead investments but commit exit 21 percentage points more often than other VCs. The real value prop isn't their capital - it's their CreditEase parent company's massive Chinese network. If you don't need China market entry, you're probably talking to the wrong fund. Fair warning: if your startup has 5+ founders, chances of getting funded are low.

Here's the thing nobody tells you about Chengwei: you're not just getting an investor, you're potentially getting entangled in one of China's most politically prominent VC personalities. Eric Li founded the nationalist news site Guancha.cn and serves on boards at China Europe International Business School. Despite the nationalist rhetoric, the fund represents a marriage of Chinese and American elites, with early investors including Donald Rumsfeld and Yale University. Data shows they're 19 percentage points more likely to achieve exits than average VCs, but 20 percentage points less likely to lead rounds. They prefer to follow rather than lead, which can be good or frustrating depending on what you need. The political connections cut both ways - great for China market access, potential baggage for global expansion.

This is the rare VC who actually writes the first check - Matt was literally Hims & Hers' first investor when it was 'merely an idea,' investing 10 months before any other external investor joined the cap table. Founders consistently describe Matt as a 'powerful force of positive energy' who's 'endlessly optimistic' and 'joyful,' with one partner noting his optimism is genuinely contagious. The relationship depth is real - founders like Andrew Dudum call Matt 'brother' after years of partnership that goes beyond just business. As one of the world's first and largest Solo GP funds, Matt has unprecedented decision-making speed, but this also means if he doesn't personally click with you, there's no Plan B. The track record speaks for itself with 12+ unicorns, but founders should know they're getting a tennis player's competitive intensity wrapped in genuine warmth.

ChrysCapital is the greybeard of Indian PE - been around since 1999 and survived every cycle, which counts for something. They successfully managed founder transition away from Ashish Dhawan, no easy feat in founder-driven firms. Portfolio companies praise their "proactive and responsive mindset," deep financial services understanding, and "quick response time." Their senior team averages 20+ years at the firm - that's institutional memory you can't buy. But here's the thing: they're big, established, and institutional. Just raised a record $2.2 billion Fund X - that's serious money that needs serious returns. If you're a scrappy startup looking for hands-on guidance and patient capital, this might feel more like partnering with a bank than a VC.